Dexcom stock is crashing Friday after the glucose monitoring company reported dismal Q2 revenue and slashed its full-year sales guidance. Here's what you need to know.
A major sell-off in the company happened Friday after it missed the top and bottom line in its 2Q24 earnings report. George Tsilis talks about how Dexcom's guidance is to blame for the falling stock.
DexCom Inc (NASDAQ:DXCM, ETR:DC4), a medical device maker that produces continuous glucose monitoring systems for diabetes management, shares plunged by more than 40% after the company slashed its an
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa

Why DexCom Stock Is Crashing Today

10:42am, Friday, 26'th Jul 2024
DexCom reported mixed Q2 results with an earnings beat, but revenue missed expectations. The company lowered its full-year revenue guidance.
Dexcom (NASDAQ: DXCM ) stock is down over 40% after reporting disappointing revenue for the second quarter. It also lowered guidance for the rest of the year.
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ: DXCM) for potential violations of the federal s
Revenue guidance was.
SAN DIEGO, July 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether DexCom, Inc. (NASDAQ: DXCM) or any of its executive officers or others violated se

Why Is DexCom (DXCM) Stock Down 38% Today?

08:29am, Friday, 26'th Jul 2024
DexCom (NASDAQ: DXCM ) stock is falling on Friday after the company released its earnings report for Q2 2024. DexCom starts its earnings report with adjusted earnings per share of 43 cents.
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Nasdaq-listed stocks have sustained a prolonged rally in recent months, reflecting investor optimism and robust market sentiment. However, in recent days, we have seen a notable pullback in several ov
Dexcom's shares sank about 38% in premarket trading on Friday after the medical device maker cut its annual revenue forecast, with analysts calling some of the issues 'self inflicted' rather than a br
DexCom reported disappointing earnings, missing estimates by 4% and lowering full-year growth expectations by ~$200 million. Sales in the U.S. market slowed, while international markets saw anemic gro
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE